Neurodyn Aims to Raise $1.5M
Neurodyn, a Charlottetown-based biotech, is working its way through a $1.5 million round of fundraising, with which it hopes to bring its own natural treatment for Parkinson’s Disease to market in just over two years.
The company, which is developing a ginseng extract called ND-602, now has commitments of about $300,000 to $400,000 and is continuing to raise money in Canada and abroad, said Chief Scientific Officer Denis Kay in an interview.
Working with the Shanghai Innovative Research Centre for Traditional Chinese Medicine, Neurodyn has discovered an extract that can arrest or slow